DEVGEN : nv: shareholder notification

Regulated information

 

Ghent - 11 March 2011 - In accordance with Article 14 of the Act of May 2, 2007 on the disclosure of major shareholdings in listed companies, Devgen nv hereby informs that it has received a shareholder notification from BT Pension Scheme Trustees Limited.

 

On 10 March 2011, BT Pension Scheme Trustees Limited declared to hold less than 3 % participation in Devgen nv.

 

For further details on the transparency declarations received by the company, reference is made to our website www.devgen.com:
http://www.devgen.com/ (investor relations).

 

About Devgen nv

 

Devgen's mission is to enable farmers to sustainably grow more food on less land, with less water, agrochemicals and labour.

 

Devgen uses advanced biotechnology and molecular breeding technology to make high yielding seeds and crop protection solutions with a superior environmental profile.

 

Devgen brings this technology to the market in the world's major food and feed crops through two complementary strategies:
-   Licensing Devgen technology for use in corn, cotton and soy and selected other crops in exchange for R&D funding, and milestone and royalty payments.
-   Producing and selling its premium hybrid seeds in major field crops such as rice, sunflower, sorghum, and pearl millet, in the Indian subcontinent and South-East Asia.

 

In its Crop Protection unit, Devgen developed an agro-chemical product that protects crops from damage by parasitic nematodes. This nematicide was launched in Turkey and in US.

 

Incorporated in 1997, Devgen has offices in Ghent (Belgium), and has subsidiaries in Singapore, Hyderabad (India), General Santos (Philippines) and Delaware (US), totaling about 280 employees.

 

For more information please contact:

 

Thierry Bogaert, CEO	Wim Goemaere, CFO
Tel. [phone]	Tel. [phone]
[e-mail]: mailto:[e-mail]	[e-mail]

 

Or visit: www.devgen.com:
http://www.devgen.com/

 

 

This press release may contain forward-looking statements containing the words "anticipates", "expects" , "intends", "plans", "estimates", "may" and "continues" as well as similar expressions. Such forward looking statements may involve known and unknown risks, uncertainties and other factors which might cause the actual results, performance or achievements of Devgen to be materially different from any future results or achievements expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, among others: agricultural risks and difficulties, including weather factors, diseases and pests, the costs and requirements of regulatory compliance and the speed with which approvals are received; public acceptance of biotechnology products; political, economic and social developments in countries where Devgen operates and other risks and factors detailed in the company's most recent annual report.
These forward looking statements speak only as of the date of publication of this document. Devgen disclaims any obligation to update such forward looking statements in this document to reflect any change in its expectations, conditions or circumstances on which such statement is based, unless required by law or regulation. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any securities issued by Devgen nv.

PR ENG:
http://hugin.info/135721/R/1496502/432254.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Devgen via Thomson Reuters ONE

HUG#1496502